A comparative QSAR on 1,2,5-thiadiazolidin-3-one 1,1-dioxide compounds as selective inhibitors of human serine proteinases.

Selective inhibitors of target serine proteinases have a potential therapeutic role for the treatment of various inflammatory and related diseases. We develop a comparative quantitative structure-activity relationships based analysis on compounds embodying the 1,2,5-thiadiazolidin-3-one 1,1-dioxide scaffold. By means of classical Molecular Dynamics we obtain the conformation of each lowest-energy molecular structure from which we derive more than a thousand of structural descriptors necessary for building predictive QSAR models. We resort to two different modeling approaches with the purpose of testing the consistency of our results: (a) multivariable linear regressions based on the replacement method and forward stepwise regression, and (b) the calculation of flexible descriptors with the CORAL program. All the models are properly validated by means of standard procedures. The resulting QSAR models are supposed to be of great utility for the rational search and design (including synthesis and/or in vitro biochemical studies) of new effective non-peptidyl inhibitors of serine proteinases.

[1]  Barry K. Lavine,et al.  Electronic van der Waals Surface Property Descriptors and Genetic Algorithms for Developing Structure-Activity Correlations in Olfactory Databases , 2003, J. Chem. Inf. Comput. Sci..

[2]  M. Fernández,et al.  QSAR analysis for heterocyclic antifungals. , 2007, Bioorganic & medicinal chemistry.

[3]  W. Groutas,et al.  Inhibition of human leukocyte elastase by derivatives of N-hydroxysuccinimide. A structure-activity-relationship study. , 1989, Journal of medicinal chemistry.

[4]  E. Castro,et al.  QSAR analysis on Spodoptera litura antifeedant activities for flavone derivatives. , 2009, The Science of the total environment.

[5]  H. Huang,et al.  Mechanism-based inhibition of human leukocyte elastase and cathepsin G by substituted dihydrouracils. , 1994, Biochimica et biophysica acta.

[6]  N. Draper,et al.  Applied Regression Analysis , 1966 .

[7]  J. Kofron,et al.  A Novel Class of Cyclic β‐Dicarbonyl Leaving Groups and Their Use in the Design of Benzisothiazolone Human Leukocyte Elastase (HLE) Inhibitors. , 1996 .

[8]  D. Underwood,et al.  Mechanism of inhibition of human leucocyte elastase by beta-lactams. 3. Use of electrospray ionization mass spectrometry and two-dimensional NMR techniques to identify beta-lactam-derived E-I complexes. , 1995, Biochemistry.

[9]  Jerzy Leszczynski,et al.  InChI-based optimal descriptors: QSAR analysis of fullerene[C60]-based HIV-1 PR inhibitors by correlation balance. , 2010, European journal of medicinal chemistry.

[10]  R. Bader.  Atoms in molecules : a quantum theory , 1990 .

[11]  Maykel Pérez González,et al.  A new search algorithm for QSPR/QSAR theories: Normal boiling points of some organic molecules , 2005 .

[12]  E. Castro,et al.  Modified and enhanced replacement method for the selection of molecular descriptors in QSAR and QSPR theories , 2008 .

[13]  W. Groutas,et al.  Inhibition of human leukocyte elastase by phosphate esters of N-hydroxysuccinimide and its derivatives: direct observation of a phosphorylated enzyme by 31P nuclear magnetic resonance spectroscopy. , 1991, Biochemistry.

[14]  A. Tropsha,et al.  Beware of q2! , 2002, Journal of molecular graphics & modelling.

[15]  G. A. Jeffrey,et al.  The Application of Charge Density Research to Chemistry and Drug Design , 1991 .

[16]  A. Krantz,et al.  Kinetics and mechanism of human leukocyte elastase inactivation by ynenol lactones. , 1987, Biochemistry.

[17]  C. Walsh,et al.  The behavior and significance of slow-binding enzyme inhibitors. , 2006, Advances in enzymology and related areas of molecular biology.

[18]  W. Groutas,et al.  Potent and specific inhibition of human leukocyte elastase, cathepsin G and proteinase 3 by sulfone derivatives employing the 1,2,5-thiadiazolidin-3-one 1,1 dioxide scaffold. , 1998, Bioorganic & medicinal chemistry.

[19]  Emilio Benfenati,et al.  Simplified Molecular Input Line Entry System‐Based Optimal Descriptors: Quantitative Structure–Activity Relationship Modeling Mutagenicity of Nitrated Polycyclic Aromatic Hydrocarbons , 2009, Chemical biology & drug design.

[20]  W. Groutas,et al.  3-(Alkylthio)-N-hydroxysuccinimide derivatives: potent inhibitors of human leukocyte elastase. , 1993, Biochimica et biophysica acta.

[21]  1,2,5-Thiadiazolidin-3-one 1,1 dioxide: a powerful scaffold for probing the S' subsites of (chymo)trypsin-like serine proteases. , 2001, Archives of biochemistry and biophysics.

[22]  W. Groutas,et al.  Inhibition of serine proteases by functionalized sulfonamides coupled to the 1,2,5-thiadiazolidin-3-one 1,1 dioxide scaffold. , 2001, Bioorganic & medicinal chemistry.

[23]  S. Wold,et al.  Statistical Validation of QSAR Results , 1995 .

[24]  N. Schechter,et al.  A General Inhibitor Scaffold for Serine Proteases with a (Chymo)trypsin-Like Fold: Solution-Phase Construction and Evaluation of the First Series of Libraries of Mechanism-Based Inhibitors , 1999 .

[25]  N. Schechter,et al.  Human chymase inhibitors based on the 1,2,5-thiadiazolidin-3-one 1,1 dioxide scaffold. , 1999, Bioorganic & medicinal chemistry letters.

[26]  Eduardo A. Castro,et al.  New Hybrid Genetic Based Support Vector Regression as QSAR Approach for Analyzing Flavonoids-GABA(A) Complexes , 2009, J. Chem. Inf. Model..

[27]  W. Groutas,et al.  Utilization of the 1,2,5-thiadiazolidin-3-one 1,1 dioxide scaffold in the design of potent inhibitors of serine proteases: SAR studies using carboxylates. , 2000, Bioorganic & medicinal chemistry.

[28]  Emilio Benfenati,et al.  SMILES in QSPR/QSAR Modeling: results and perspectives. , 2007, Current drug discovery technologies.

[29]  Apilak Worachartcheewan,et al.  Modeling the activity of furin inhibitors using artificial neural network. , 2009, European journal of medicinal chemistry.

[30]  H. Kubinyi.  QSAR : Hansch analysis and related approaches , 1993 .

[31]  Alan Talevi,et al.  New QSPR study for the prediction of aqueous solubility of drug-like compounds. , 2008, Bioorganic & medicinal chemistry.

[32]  Roberto Todeschini,et al.  Molecular descriptors for chemoinformatics , 2009 .

[33]  J. Katzenellenbogen,et al.  Enol lactone derivatives as inhibitors of human neutrophil elastase and trypsin-like proteases , 1992 .

[34]  Douglas M. Hawkins,et al.  Assessing Model Fit by Cross-Validation , 2003, J. Chem. Inf. Comput. Sci..

[35]  J. Kofron,et al.  A novel class of cyclic beta-dicarbonyl leaving groups and their use in the design of benzisothiazolone human leukocyte elastase inhibitors. , 1995, Journal of Medicinal Chemistry.

[36]  B. Gilks,et al.  Acute cigarette smoke-induced connective tissue breakdown is mediated by neutrophils and prevented by alpha1-antitrypsin. , 2000, American journal of respiratory cell and molecular biology.

[37]  H. Huang,et al.  Efficient inhibition of human leukocyte elastase and cathepsin G by saccharin derivatives. , 1993, Journal of medicinal chemistry.

[38]  A. Tropsha,et al.  Beware of q 2 , 2002 .

[39]  Han van de Waterbeemd,et al.  Chemometric methods in molecular design , 1995 .

[40]  P. Barnes,et al.  Novel approaches and targets for treatment of chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[41]  M. Fernández,et al.  QSAR for non-nucleoside inhibitors of HIV-1 reverse transcriptase. , 2006, Bioorganic & medicinal chemistry.

[42]  R. Stockley.  The role of proteinases in the pathogenesis of chronic bronchitis. , 1994, American journal of respiratory and critical care medicine.

[43]  R. Gordon,et al.  Orally bioavailable benzisothiazolone inhibitors of human leukocyte elastase. , 1995, Journal of medicinal chemistry.

[44]  José Dias Curto,et al.  New Multicollinearity Indicators in Linear Regression Models , 2007 .

[45]  E Benfenati,et al.  Additive SMILES-based optimal descriptors in QSAR modelling bee toxicity: Using rare SMILES attributes to define the applicability domain. , 2008, Bioorganic & medicinal chemistry.

[46]  W. Groutas,et al.  Potent inhibition of serine proteases by heterocyclic sulfide derivatives of 1,2,5-thiadiazolidin-3-one 1,1 dioxide. , 2000, Bioorganic & medicinal chemistry.

[47]  O. Prakash,et al.  Structure-based design of a general class of mechanism-based inhibitors of the serine proteinases employing a novel amino acid-derived heterocyclic scaffold. , 1997, Biochemistry.